REACH and the cosmetics industry - Alan Ritchie Senior Consultant Caleb Management Services Ltd 18 June 2008
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
REACH and the cosmetics industry Alan Ritchie Senior Consultant Caleb Management Services Ltd 18 June 2008 1
Summary of today’s presentation • Pre-registration, SIEFs and consortia • Downstream users • Testing • Commercial consequences of REACH • Relevant Caleb Experience 2
Pre-registration, SIEFs and consortia • What is involved in pre-registration: – does the substance have to be registered (Annex IV and V exemptions, “naturals”); • Annex IV - Exemptions from the obligation to register in accordance with article 2(7)(a) – List of specific substances – List not very logical » e.g. lauric (C12 linear fatty acid), and palmitic (C16 linear fatty acid) listed; myristic (C14 linear fatty acid) is not… » Commission reviewing list » Updated list not ready for start of pre-registration – may not be published before pre-registration ends • Conclusion: if not listed: PRE-REGISTER! 3
Pre-registration, SIEFs and consortia – Annex V - Exemptions from the obligation to register in accordance with article 2(7)(b) • Lists 9 categories: critical for cosmetics industry: 8. Substances occurring in nature other than those listed under paragraph 7, if they are not chemically modified, unless they meet the criteria for classification as dangerous according to Directive 67/548/EEC. • Natural not necessarily exempt: – Chemical processing (e.g. solvent extraction – INCLUDES e.g. SCFE) – Classified as dangerous 4
Pre-registration, SIEFs and consortia • Difficulties: – Ambiguous CAS numbers; • Substance characterised by different CAS numbers in different jurisdictions; • No CAS registry entry – Does it qualify as “phase-in” or not; • Must be on EINECS or non-listed NLP – But who owns the NLP if not listed? 5
Pre-registration, SIEFs and consortia – Non EINECS listed products • Notified? • If not on EINECS and not notified, must be registered, but no benefits to pre-registration • Maybe no SIEF required – Reaction mixtures/substances of unknown/variable composition; 1. Substance …chemical element and its compounds in the natural state or obtained by any manufacturing process, including any additive necessary to preserve its stability and any impurity deriving from the process used, but excluding any solvent which may be separated without affecting the stability of the substance or changing its composition; 6
Pre-registration, SIEFs and consortia – Why do some substances not have CAS numbers; what about notified substances? • Notified substances deemed to be registered, but… such substances in a cosmetic formulation excluded from notified volumes under 67/548, but included under REACH 7
Pre-registration, SIEFs and consortia • How does a SIEF form; – How do I know who the other players are? • SIEFs/consortia: – What’s the difference? • SIEFs are bound by REACH rules, but competition law takes precedence; • Only EU legal entities (including ORs) can join SIEFs • Consortia are legal entities • Can commission testing and spend $ • Anyone can join – EU or not 8 Wh f ti ?
Downstream users • What is a downstream user? • Definition 13 … any natural or legal person established within the Community, other than the manufacturer or the importer, who uses a substance, either on its own or in a preparation, in the course of his industrial or professional activities. • When does a DU become a manufacturer/importer? – Changes where substance is bought – Meaning of “importer” under REACH • Made overseas and brought into EU 9
Downstream users • What are a DU’s responsibilities under REACH? Whereas 58: “In order to have a chain of responsibilities, downstream users should be responsible for assessing the risks arising from their uses of substances if those uses are not covered by a safety data sheet received from their suppliers, unless the downstream user concerned takes more protective measures than those recommended by his supplier or unless his supplier was not required to assess those risks or provide him with information on those risks. For the same reason, downstream users should manage the risks arising from their uses of substances…” 10
Downstream users • What are a DU’s responsibilities under REACH? – Reporting up the supply chain – Confidentiality issues – Exposure information – Registered uses 11
Testing • Costs/tonnage band (worst case scenario 1) (per substance): 1-10 10-100 100-1000 >1000 tonnes tonnes tonnes tonnes $80,357 $347,359 $1,754,326 $4,217,079 €45,400 €196,100 €990,300 €2,380,500 1 Assuming no data available at all, no waivers exemptions or derogations, no read across/surrogate data • Therefore: conduct an impact assessment! 12
Testing • Likely test gaps: – Likely to vary a lot from one substance and one company to another – Probable environmental gaps 13
Testing • How can certain tests be avoided? – Polymers (but not NLPs) – Not relevant/appropriate/not technically possible (e.g. granulometry for fluids) – Not necessary due to exposure patterns (e.g. inhalation toxicity for substances only used in dermal preparations) – Read across/surrogate data – Grouping – QSARs – Available data for another endpoint makes test unnecessary – Substance of low inherent stability (many tests can be waived if a substance is biodegradable) 14
Testing • What about the Cosmetics Directive animal testing ban? – Are tests conducted for REACH applicable – French decision – Positive listing (preservatives, UV absorbers, pigments) – Other jurisdictions – Other applications ? 15
Commercial consequences of REACH • Registration costs (Standard) Tonnage SMEs in category Individual Joint SMEs a SIEF 1 – 10 t € 1,600 € 800 € 900 € 500 >10 t – 100 t € 4,360 € 2,180 € 2,440 € 1,370 >100 t – 1000 t € 11,500 € 5,925 € 6,630 € 3,715 >1000 t € 31,000 € 16,080 € 18,000 € 10,080 16
Commercial consequences of REACH • Registration costs (reduced) Medium Medium Small Small Micro Micro Enterprise Enterprise Enterprise Enterprise Enterprise Enterprise (Individual (Joint (Individual (Joint (Individual (Joint Submission) Submission) Submission) Submission) Submission) Submission) 1-10 t € 1,120 € 840 € 640 € 480 € 160 € 120 10- 100 t € 3,010 € 2,258 € 1,720 € 1,290 € 430 € 323 100 - 1000 t € 8,050 € 6,038 € 4,600 € 3,450 € 1,150 € 863 >1000 t € 21,700 € 16,275 € 12,400 € 9,300 € 3,100 € 2,325 17
Commercial consequences of REACH - Testing (recap) • Costs/tonnage band (worst case scenario 1 (per substance): 1-10 10-100 100-1000 >1000 tonnes tonnes tonnes tonnes $80,357 $347,359 $1,754,326 $4,217,079 €45,400 €196,100 €990,300 €2,380,500 1 Assuming no data available at all, no waivers exemptions or derogations, no read across/surrogate data 18
What are the big issues for the cosmetics industry? • Costs of data generation • Substances legally imported into EU as part of a cosmetics formulation but which do not qualify for phase-in status (e.g. not on EINECS) • The animal testing conundrum 19
What are the big issues for the cosmetics industry? • Product availability issues: – Rationalisation; – Reformulation; – Preservative availability due to • REACH • BPD • Other issues (endocrine effects, formaldehyde, sensitisation, costs of support with Cosmetics Annex listing required testing e.g. branch chain parabens) 20
Introduction to Caleb Management Services (1) • Consultancy established in 1994 by Paul Ashford (MD) - have worked in chemical risk assessment since then • Extensive experience in managing Task Forces and consortia for OECD SIDS and US HPV Challenge Programmes • Five key personnel with chemical expertise and proven REACH experience 21
Introduction to Caleb Management Services (2) • Approved REACHReady Service Provider • Contracted advisory roles with chemical trade associations (including complex product portfolios) • REACH consortia are already emerging from these relationships • Contracted as Only Representative to non- EU manufacturers 22
Introduction to Caleb Management Services (3) • Services offered: – REACH Training – REACH Impact Assessments – Consortium formation and management – Third Party representation – Only representative – Pre-registration and registration support – EU regulatory advice 23
You can also read